More articles from Pulmonary vascular disease

Plasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation
Joanna Säleby, Habib Bouzina, Salaheldin Ahmed, Jakob Lundgren, Göran Rådegran

ERJ Open Research Oct 2019, 5 (4) 00037-2019; DOI: 10.1183/23120541.00037-2019
Sex-specific differences and survival in patients with idiopathic pulmonary arterial hypertension 2008–2016
Barbro Kjellström, Magnus Nisell, David Kylhammar, Sven-Erik Bartfay, Bodil Ivarsson, Göran Rådegran, Clara Hjalmarsson

ERJ Open Research Jul 2019, 5 (3) 00075-2019; DOI: 10.1183/23120541.00075-2019
A retrospective analysis of outcomes in low- and intermediate–high-risk pulmonary embolism patients managed on an ambulatory medical unit in the UK
Michael E. Reschen, Jonathan Raby, Jordan Bowen, Sudhir Singh, Daniel Lasserson, Christopher A. O'Callaghan

ERJ Open Research Apr 2019, 5 (2) 00184-2018; DOI: 10.1183/23120541.00184-2018
Metformin added to bosentan therapy in patients with pulmonary arterial hypertension associated with congenital heart defects: a pilot study
Shutan Liao, Dongsheng Li, Zheng Hui, Craig S. McLachlan, Yang Zhang

ERJ Open Research Jul 2018, 4 (3) 00060-2018; DOI: 10.1183/23120541.00060-2018

Main menu